Neurodevelopmental disorder and immunodeficiency
Abstract
Background: Neurodevelopment is closely entwined with immune maturation and function during embryogenesis. While haematopoietic-derived microglia have recognized roles in a number of neurodevelopmental processes, the contribution of molecules classically involved in the immune system (including complement, toll-like receptors, and cytokines) are also emerging. To date, approximately 11% of genes known to cause primary immunodeficiency also confer varying degrees of neurological abnormalities. These can range from intellectual disability, cognitive and behavioural disorders, through to seizures, spasticity, and motor development delay. However, very rarely are sensory processing defects associated with aberrations of the immune system.
Aims: To define the clinical presentation and immune phenotype of a novel syndrome encompassing immunodeficiency, neurodevelopmental abnormalities, and altered pain sensitivity in two siblings.
Methods: Comprehensive retrospective review of the patient’s charts were performed, in accordance with local research ethics board approval.
Results: We describe two teenage sisters who presented with recurrent sinopulmonary infections, lymphopenia affecting both B and T cells, developmental delay, learning and processing disorder, seizures, and reduced sensitivity to pain. Other features include bronchogenic cyst, microscopic hematuria, oral ulcers, papular urticaria, and keratosis pilaris.
Conclusion: An underlying defect in genes known to cause primary immunodeficiency was not identified, suggesting the role of an as-yet undefined molecule at the crossroads of immunity, neurodevelopment, and sensory processing.
Statement of novelty: We report on two patients, siblings, with a novel phenotype of combined immunodeficiency, neurodevelopmental delay, and reduced sensitivity to painful stimuli.
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
Barak B., Feldman N., and Okun E. 2014. Toll-like receptors as developmental tools that regulate neurogenesis during development: an update. Front Neurosci, 8: 272.
Baudouin S.J., Angibaud J., Loussouarn G., Bonnamain V., Matsuura A., Kinebuchi M., Naveilhan P., and Boudin H. 2008. The signaling adaptor protein CD3zeta is a negative regulator of dendrite development in young neurons. Mol Biol Cell. 19: 2444–2456.
Borsini A., Zunszain P.A., Thuret S., and Pariante C.M. 2015. The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 38: 145–157.
Bousfiha A., Moundir A., Tangye S. G., Picard C., Jeddane L., Al-Herz W., Rundles C.C., Franco J.L., Holland S. M., Klein C., Morio T., Oksenhendler E., Puel A., Puck J., Seppänen M.R.J., Somech R., Su H.C., Sullivan K.E., Torgerson T.R., and Meyts I. 2022. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J. Clin. Immunol. 42: 1508–1520.
Cunningham C.L., Martínez-Cerdeño V., and Noctor S.C. 2013. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci 33: 4216–4233.
Filipello F., Morini R., Corradini I., Zerbi V., Canzi A., Michalski B., Erreni M., Markicevic M., Starvaggi-Cucuzza C., Otero K., Piccio L., Cignarella F., Perrucci F., Tamborini M., Genua M., Rajendran L., Menna E., Vetrano S., Fahnestock M., Paolicelli R. C., and Matteoli M. 2018. The microglial innate immune receptor TREM2 Is required for synapse elimination and normal brain connectivity. Immunity, 48: 979–991.e8.
Kim J-H., Deepali N.S., Margot R.F.R., Hauser N.S., Belmonte R.L., Wilson G.R., Bosch D.G.M., Bubulya P.A., Shashi V., Petrovski S., Stone J.K., Park E.Y., Veltman J.A., Sinnema M., Stumpel C.T.R.M., Draaisma J.M., Nicolai J., Yntema H.G., Lindstrom K., De Vries B.B.A., Jewett T., Santoro S.L., Vogt J., Bachman K.K., Seeley A.H., Krokosky A., Turner C., Rohena L., Hempel M., Kortüm F., Lessel D., Neu A., Strom T.M., Wieczorek D., Bramswig N., Laccone F.A., Behunova J., Rehder H., Gordon C.T., Rio M., Romana S., Tang S., El-Khechen D., Cho M.T., Mcwalter K., Douglas G., Baskin B., Begtrup A., Funari T., Schoch K., Stegmann A.P.A., Stevens S.J.C., Zhang D.-E., Traver D., Yao X., Macarthur D.G., Brunner H.G., Mancini G.M., Myers R.M., Owen L.B., Lim S-T., Stachura, David L.V., Lisenka E.L.M., and Ahn E-Y.E. 2016. De novo mutations in son disrupt rna splicing of genes essential for brain development and metabolism, causing an intellectual-disability syndrome. Am J Hum Genet 99: 711–719.
Kipnis J., Cohen H., Cardon M., Ziv Y., and Schwartz M. 2004. T cell deficiency leads to cognitive dysfunction: Implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc. Natl. Acad. Sci. 101: 8180–8185.
Lammert C.R., Frost E.L., Bellinger C.E., Bolte A.C., Mckee C.A., Hurt M.E., Paysour M.J., Ennerfelt H.E., and Lukens J.R. 2020. AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment. Nature, 580: 647–652.
Lenz K.M. and Nelson L.H. 2018. Microglia and beyond: innate immune cells as regulators of brain development and behavioral function. Front Immunol, 9: 698.
Marín-Teva, J.L., Dusart, I., Colin, C., Gervais, A., Van Rooijen, N., and Mallat, M. 2004. Microglia promote the death of developing purkinje cells. Neuron, 41: 535–547.
Mcdonald-Mcginn, D.M., and Sullivan, K.E. 2011. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine, 90: 1–18.
Merico D., Roifman M., Braunschweig U., Yuen R.K.C., Alexandrova R., Bates A., Reid B., Nalpathamkalam T., Wang Z., Thiruvahindrapuram B., Gray P., Kakakios A., Peake J., Hogarth S., Manson D., Buncic R., Pereira S.L., Herbrick J-A., Blencowe B.J., Roifman C.M., and Scherer S.W. 2015. Compound heterozygous mutations in the noncoding RNU4ATAC cause roifman syndrome by disrupting minor intron splicing. Nat Commun. 6: 8718.
Morimoto K. and Nakajima K. 2019. Role of the Immune System in the Development of the central nervous system. Front Neurosci. 13: 916.
Nakamura K., Hirai H., Torashima T., Miyazaki T., Tsurui H., Xiu Y., Ohtsuji M., Lin Q. S., Tsukamoto K., Nishimura H., Ono M., Watanabe M., and Hirose S. 2007. CD3 and immunoglobulin G Fc receptor regulate cerebellar functions. Mol Cell Biol. 27: 5128–5134.
Ren K. and Dubner R. 2010. Interactions between the immune and nervous systems in pain. Nat Med, 16: 1267–76.
Roifman C.M. 1997. Immunological aspects of a novel immunodeficiency syndrome that includes antibody deficiency with normal immunoglobulins, spondyloepiphyseal dysplasia, growth and developmental delay, and retinal dystrophy. Can. J. Allergy Clin. Immun. 2: 94–98.
Roifman C.M. 1999. Antibody deficiency, growth retardation, spondyloepiphyseal dysplasia and retinal dystrophy: a novel syndrome. Clin. Genet. 55: 103–109.
Stepensky P., Rensing-Ehl A., Gather R., Revel-Vilk S., Fischer U., Nabhani S., Beier F., Brummendorf T.H., Fuchs S., Zenke S., Firat E., Pessach V.M., Borkhardt A., Rakhmanov M., Keller B., Warnatz K., Eibel H., Niedermann G., Elpeleg O., and Ehl S. 2015. Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency. Blood, 125: 753–761.
Stephan A.H., Barres B.A., and Stevens B. 2012. The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 35: 369–389.
Takenouchi T., Miura K., Uehara T., Mizuno S., and Kosaki K. 2016. Establishing SON in 21q22.11 as a cause a new syndromic form of intellectual disability: Possible contribution to braddock-carey syndrome phenotype. Am. J. Med. Genet. Part A, 170: 2587–2590.
Tangye S. G., Al-Herz W., Bousfiha A., Cunningham-Rundles C., Franco J. L., Holland S. M., Klein C., Morio T., Oksenhendler E., Picard C., Puel A., Puck J., Seppänen M.R.J., Somech R., Su H.C., Sullivan K.E., Torgerson T.R., and Meyts I. 2022. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J. Clin. Immunol. 42: 1473–1507.
Veerhuis R., Nielsen H.M., and Tenner A.J. 2011. Complement in the brain. Mol Immunol, 48: 1592–603.
Zengeler K.E. and Lukens J.R. 2021. Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders. Nat. Rev. Immunol., 21: 454–468.
Information & Authors
Information
Published In
LymphoSign Journal
Volume 10 • Number 3 • September 2023
Pages: 42 - 47
History
Received: 3 August 2023
Accepted: 30 August 2023
Accepted manuscript online: 30 August 2023
Version of record online: 19 October 2023
Copyright
© 2023.
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
Chaim M.Roifman and LindaVong. 2023. Neurodevelopmental disorder and immunodeficiency. LymphoSign Journal.
10(3): 42-47. https://doi.org/10.14785/lymphosign-2023-0008
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
There are no citations for this item
View Options
Login options
Check if you access through your login credentials or your institution to get full access on this article.
